Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats

Molecular Vision

Volumn 19, Issue , 2013, Pages 2477-2486

  Takamura, Yoshihiro ^a   Matsumoto, Takafumi ^b   Tomomatsu, Takeshi ^a   Matsumura, Takehiro ^a   Takihara, Yuji ^a   Inatani, Masaru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; GALACTITOL; GALACTOSE; HEPTANOL; MESSENGER RNA; RANIRESTAT; RECOMBINANT ENZYME; RECOMBINANT MATRIX METALLOPROTEINASE 10; STROMELYSIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA EROSION; CORNEA INJURY; DIABETES MELLITUS; DIABETIC KERATOPATHY; DRUG EFFICACY; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KERATOPATHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; WESTERN BLOTTING; WOUND HEALING;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ALDEHYDE REDUCTASE; ANIMALS; CORNEAL DYSTROPHIES, HEREDITARY; DIABETES MELLITUS, EXPERIMENTAL; DIET; ENZYME INHIBITORS; EPITHELIUM, CORNEAL; GALACTITOL; GALACTOSE; GENE EXPRESSION REGULATION; INTEGRIN ALPHA3; MALE; MATRIX METALLOPROTEINASE 10; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84889666211     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004; 27:2540-53. [PMID: 15451934].
2. Bikbova G, Oshitari T, Tawada A, Yamamoto S. Corneal changes in diabetes mellitus. Curr Diabetes Rev 2012; 8:294-302. [PMID: 22587515].
3. Perry HD, Foulks GN, Thoft RA, Tolentino FI. Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol 1978; 96:1401-3. [PMID: 678179].
4. Chung H, Tolentino FI, Cajita VN, Acosta J, Refojo MF. Reevaluation of corneal complications after closed vitrectomy. Arch Ophthalmol 1988; 106:916-9. [PMID: 3390054].
5. Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol 1979; 97:1076-8. [PMID: 444136].
6. Kinoshita JH, Fukushi S, Kador P, Merola LO. Aldose reductase in diabetic complications of the eye. Metabolism 1979; 28:Suppl 1462-9. [PMID: 45423].
7. Cogan DG, Kinoshita JH, Kador PF, Robison G, Datilis MB, Cobo LM, Kupfer C. NIH conference. Aldose reductase and complications of diabetes. Ann Intern Med 1984; 101:82-91. [PMID: 6203454].
8. Akagi Y, Yajima Y, Kador PF, Kuwabara T, Kinoshita JH. Localization of aldose reductase in the human eye. Diabetes 1984; 33:562-6. [PMID: 6427040].
9. Kaji Y, Usui T, Oshika T, Matsubara M, Yamashita H, Araie M, Murata T, Ishibashi T, Nagai R, Horiuchi S, Amano S. Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 2000; 41:362-8. [PMID: 10670463].
10. Kaji Y, Amano S, Usui T, Suzuki K, Tanaka S, Oshika T, Nagai R, Horiuchi S. Advanced glycation end products in Descemet's membrane and their effect on corneal endothelial cell. Curr Eye Res 2001; 23:469-77. [PMID: 12045898].
11. Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 2001; 24:479-82. [PMID: 11289471].
12. Hallberg CK, Trocme SD, Ansari NH. Acceleration of corneal wound healing in diabetic rats by the antioxidant trolox. Res Commun Mol Pathol Pharmacol 1996; 93:3-12. [PMID: 8865365].
13. Schäfer M, Werner S. Oxidative stress in normal and impaired wound repair. Pharmacol Res 2008; 58:165-71. [PMID: 18617006].
14. Jacot JL, Hosotani H, Glover JP, Lois N, Robison WG Jr. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors. J Ocul Pharmacol Ther 1998; 14:169-80. [PMID: 9572543].
15. Kubo E, Nakamura S, Tsuzuki S, Takahashi Y, Akagi Y, Mizuno K, Matsubara A. Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats. Graefe's archive for clinical and experimental ophthalmology Albrecht Von Graefes Arch Klin Exp Ophthalmol 1999; 237:758-62.
16. Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci 1983; 24:563-9. [PMID: 6841002].
17. Fukushi S, Merola LO, Tanaka M, Datiles M, Kinoshita JH. Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res 1980; 31:611-21. [PMID: 6778708].
18. Friend J, Thoft RA. The diabetic cornea. Int Ophthalmol Clin 1984; 24:111-23. [PMID: 6500867].
19. Yokoi N, Niiya A, Komuro A, Yokogaki S, Naka H, Awata T, Honma Y, Yamada J, Tei M, Kinoshita S. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats. Curr Eye Res 1997; 16:595-9. [PMID: 9192169].
20. Awata T, Sogo S, Yamagami Y, Yamamoto Y. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats. J Ocul Pharmacol 1988; 4:195-201. [PMID: 3143793].
21. Hosotani H, Ohashi Y, Kinoshita S, Matsumoto T, Awata T. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats. Curr Eye Res 1996; 15:1005-7. [PMID: 8921238].
22. Fujishima H, Tsubota K. Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br J Ophthalmol 2002; 86:860-3. [PMID: 12140204].
23. Nakahara M, Miyata K, Otani S, Miyai T, Nejima R, Yamagami S, Amano S. A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients. Br J Ophthalmol 2005; 89:266-8. [PMID: 15722300].
24. Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, Miner JH, Ninomiya Y, Sado Y, Kenney MC. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 1998; 46:1033-41. [PMID: 9705969].
25. Saghizadeh M, Brown DJ, Castellon R, Chwa M, Huang GH, Ljubimova JY, Rosenberg S, Spirin KS, Stolitenko RB, Adachi W, Kinoshita S, Murphy G, Windsor LJ, Kenney MC, Ljubimov AV. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol 2001; 158:723-34. [PMID: 11159210].
26. Kabosova A, Kramerov AA, Aoki AM, Murphy G, Zieske JD, Ljubimov AV. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp Eye Res 2003; 77:211-7. [PMID: 12873452].
27. Tomomatsu T, Takamura Y, Kubo E, Akagi Y. Aldose reductase inhibitor counteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression. Diabetes Res Clin Pract 2009; 86:16-23. [PMID: 19682763].
28. Chung JH, Kim WK, Lee JS, Pae YS, Kim HJ. Effect of topical Na-hyaluronan on hemidesmosome formation in n-heptanol-induced corneal injury. Ophthalmic Res 1998; 30:96-100. [PMID: 9523287].
29. Liang HR, Takagaki T, Foltz RL, Bennett P. Quantitative determination of endogenous sorbitol and fructose in human erythrocytes by atmospheric-pressure chemical ionization LC tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 824:36-44. [PMID: 16061433].
30. radford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54. [PMID: 942051].
31. Saghizadeh M, Kramerov AA, Yaghoobzadeh Y, Hu J, Ljubimova JY, Black KL, Castro MG, Ljubimov AV. Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes. Brain Res Bull 2010; 81:262-72. [PMID: 19828126].
32. Carter RT, Kambampati R, Murphy CJ, Bentley E. Expression of matrix metalloproteinase 2 and 9 in experimentally wounded canine corneas and spontaneous chronic corneal epithelial defects. Cornea 2007; 26:1213-9. [PMID: 18043179].
33. Petznick A, Madigan MC, Garrett Q, Sweeney DF, Evans MD. Contributions of Ocular Surface Components to Matrix-Metalloproteinases (MMP)-2 and MMP-9 in Feline Tears following Corneal Epithelial Wounding. PLoS ONE 2013; 8:e71948 [PMID: 23977185].
34. Kim HS, Shang T, Chen Z, Pflugfelder SC, Li DQ. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Exp Eye Res 2004; 79:263-74. [PMID: 15325573].
35. Li DQ, Shang TY, Kim HS, Solomon A, Lokeshwar BL, Pflugfelder SC. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2003; 44:2928-36. [PMID: 12824233].
36. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Decreased penetration of anchoring fibrils into the diabetic stroma. A morphometric analysis. Arch Ophthalmol 1989; 107:1520-3. [PMID: 2803103].
37. Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, Parks WC, Birkland TP, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E, Paramo JA. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. Circulation 2011; 124:2909-19. [PMID: 22104553].
38. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA 1995; 92:2780-4. [PMID: 7708723].
39. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res 1974; 19:577-82. [PMID: 4442467].